Aslera™ improves lupus disease activity and symptoms
...fe parameters. In addition, for a patient to be a responder she could not have experienced clinical deterioration. The treatment groups were well balanced for baseline characteristics. The Aslera™ group had significantly more responders, 66 percent vs. 49 percent on placebo (p=0.005). Also, there was ...New hope for preventing major problems of the retina
...tor pathways like catecholamine receptors, a major responder to stress. Vascular dopaminergic effects in the eye in past studies have revealed that dopamine antagonists (domperidone and haloperidol) increase ocular blood flow in rabbits. Other dopamine antagonists had similar effects, whereas dopamine agonists...Cyclacel's biomarker technology shows that CYC202 induces cancer cells to commit suicide
... trials and market positioning by helping identify responder patients based on their genetic profile. We are excited about the work of our talented Biomarker Team and our goal of converting our understanding of biological pathways into patient treatment guidelines. We expect to use our Biomarker technology i...